With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD||Innovation Grants||2019||New York|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||Medical University of South Carolina / Meenal Mehrotra, MD/PhD||Innovation Grants||2019||South Carolina|
|Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2019||Pennsylvania|
|Identifying targeted treatments for DICER1-associated sarcomas||Research Institute of the McGill University Health Centre / William Foulkes, MD/PhD & Sidong Huang, PhD||Innovation Grants||2019||Quebec|
|The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade||University of Florida / Catherine Flores, PhD||Innovation Grants||2019||Florida|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome||Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD||Epidemiology Grants||2019||Pennsylvania|